Comprehensive medication guide to Oxybutynin including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$15 copay for generic oxybutynin on most private insurance plans; typically Tier 1–2 on most formularies. Medicare Part D covers generic oxybutynin at low cost, usually $0–$10 per month after the deductible. No prior authorization typically required for generic.
Estimated Cash Pricing
$29–$57 retail for generic oxybutynin 5 mg IR tablets (30-day supply); as low as $4.81–$15.87 with GoodRx or SingleCare coupons. Generic oxybutynin ER averages $78.80 retail but can be found for as little as $6.60 with GoodRx.
Medfinder Findability Score
88/100
Summarize with AI
On this page
Oxybutynin is an FDA-approved prescription medication used to treat overactive bladder (OAB) — a condition characterized by sudden urges to urinate, urinary frequency, and urge incontinence. It is also used for neurogenic bladder conditions in adults and children. Brand names include Ditropan XL (extended-release oral tablet) and Oxytrol (transdermal patch, available over-the-counter for women).
Oxybutynin has been on the market since the 1970s and is one of the most extensively studied OAB medications. It is available in five formulations: immediate-release (IR) tablets, extended-release (ER) tablets, oral syrup, topical gel, and a transdermal patch. The extended-release formulation is generally preferred because it requires once-daily dosing and causes significantly less dry mouth than the IR version.
In addition to its FDA-approved uses, oxybutynin is frequently prescribed off-label for hyperhidrosis (excessive sweating), where its ability to block sweat gland activity provides meaningful relief. This use has expanded the patient population for oxybutynin significantly since the 2010s.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Oxybutynin is an anticholinergic (antimuscarinic) drug. It works by competitively blocking muscarinic acetylcholine receptors — specifically the M1, M2, and M3 subtypes — on the detrusor (bladder wall) muscle. By preventing acetylcholine from binding to these receptors, oxybutynin stops the involuntary nerve signals that trigger the bladder to contract unexpectedly. The result is increased bladder capacity, reduced urgency, and fewer episodes of urge incontinence.
Because oxybutynin is not bladder-selective, it also blocks muscarinic receptors in the salivary glands, GI tract, sweat glands, and eyes — which explains its broad side effect profile including dry mouth, constipation, and decreased sweating. When oxybutynin is taken orally, first-pass liver metabolism produces a potent active metabolite (N-desethyloxybutynin) that contributes substantially to these systemic anticholinergic effects.
Topical and transdermal formulations bypass this first-pass metabolism, resulting in much lower levels of the active metabolite and a significantly better systemic tolerability profile — making the patch the best-tolerated form of oxybutynin for patients who are sensitive to anticholinergic side effects.
5 mg — Immediate-release tablet
Taken 2-3 times daily; max 5 mg four times daily (20 mg/day)
5 mg, 10 mg, 15 mg — Extended-release tablet (Ditropan XL)
Taken once daily; start 5-10 mg; titrate by 5 mg/week; max 30 mg/day
5 mg/5 mL — Oral syrup
Taken 2-4 times daily; used in pediatric patients or those who cannot swallow tablets
Topical gel — Gel applied to skin
Applied once daily to abdomen, thigh, or upper arm; bypasses first-pass metabolism
3.9 mg/day — Transdermal patch (Oxytrol)
Applied to skin twice weekly; OTC available for women; lowest systemic side effect burden
Oxybutynin is generally widely available at retail pharmacies across the United States. As of 2026, there is no FDA-designated shortage of oxybutynin. Multiple generic manufacturers — including Mylan, Teva, and Zydus — produce it in several formulations, which supports a stable national supply.
However, local pharmacy stocking can be inconsistent, particularly for less common formulations: the topical gel and oral syrup are not universally stocked, and even the 2.5 mg IR tablet (used in geriatric patients) may require advance ordering at some pharmacies. The standard 5 mg IR tablet and 10 mg ER tablet are the easiest to find.
If you're having trouble finding oxybutynin at your pharmacy, medfinder can help. medfinder calls pharmacies near you to check which ones have your specific formulation in stock, then texts you the results — saving you hours on hold.
Oxybutynin is not a controlled substance, so any licensed prescriber with a standard DEA registration can prescribe it. No special certification or DEA Schedule II waiver is required. This makes oxybutynin broadly accessible through a wide range of providers.
Providers who commonly prescribe oxybutynin include:
Because oxybutynin is not a controlled substance, it can also be prescribed via telehealth in all 50 states, making it accessible through platforms like Teladoc, MDLive, and primary care patient portals without requiring an in-person visit.
No. Oxybutynin is not a controlled substance and is not scheduled by the DEA. It has no abuse potential and does not require any special prescribing certification beyond a standard state medical license.
Because it is not a controlled substance, oxybutynin can be prescribed via telehealth in all 50 states without the restrictions that apply to Schedule II-IV medications. It also has no refill quantity limits or prescription monitoring program (PMP) requirements that typically apply to scheduled drugs.
Common side effects include:
Serious side effects requiring immediate attention:
Know what you need? Skip the search.
Tolterodine (Detrol LA)
Antimuscarinic in the same class as oxybutynin; more bladder-selective with fewer systemic side effects; generic available at comparable cost
Mirabegron (Myrbetriq)
Beta-3 adrenergic agonist; different mechanism with no anticholinergic side effects; preferred alternative for older adults and those who cannot tolerate dry mouth; brand-name only
Solifenacin (Vesicare)
Once-daily antimuscarinic; more bladder-selective than oxybutynin; generic available; similar efficacy with somewhat fewer side effects
Vibegron (Gemtesa)
Newest beta-3 agonist; once-daily; no anticholinergic effects; no blood pressure elevation risk (vs. mirabegron); brand-name only
Prefer Oxybutynin? We can find it.
Ketoconazole / Itraconazole (azole antifungals)
majorCYP3A4 inhibitors that double oxybutynin plasma concentrations; may require dose reduction of oxybutynin
Clarithromycin / Erythromycin (macrolide antibiotics)
moderateCYP3A4 inhibitors that increase oxybutynin exposure; monitor for increased anticholinergic side effects
Diphenhydramine (Benadryl) and other antihistamines
moderateAdditive anticholinergic effects; significantly increases risk of dry mouth, constipation, urinary retention, and confusion
Donepezil / Rivastigmine (cholinesterase inhibitors)
majorOxybutynin antagonizes the mechanism of cholinesterase inhibitors used for Alzheimer's; reduces effectiveness of dementia treatment
Alcohol and CNS depressants
moderateAdditive sedation and CNS depression; avoid alcohol; use caution with benzodiazepines and opioids
Tricyclic antidepressants (amitriptyline, nortriptyline)
moderateAdditive anticholinergic burden; increased risk of constipation, urinary retention, and cognitive effects
Oxybutynin remains one of the most clinically proven and cost-effective treatments for overactive bladder available in 2026. With decades of safety data, multiple formulation options, and generic availability at prices as low as $4.81 per month, it is accessible to most patients. The key to successful therapy is choosing the right formulation — the extended-release tablet or transdermal patch are much better tolerated than the immediate-release form and should be preferred for most patients.
Elderly patients (65+) should have a frank conversation with their provider about oxybutynin's anticholinergic cognitive risks and whether a beta-3 agonist (mirabegron or vibegron) would be more appropriate for their situation. For younger adults without cognitive concerns and who are cost-sensitive, generic oxybutynin ER is an outstanding value.
If you are struggling to find oxybutynin at your pharmacy, medfinder is here to help. Simply provide your medication details and location, and medfinder calls pharmacies near you to find which ones can fill your prescription. Results are texted to you — no hold times, no pharmacy hopping.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards